IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling

Mesenchymal stem cells (MSCs) hold great promise as potential therapies for tumors through the delivery of various anticancer agents. However, exogenous tissue-derived MSCs, such as those of bone marrow, have exhibited a tendency for malignant transformation in the tumor microenvironment. This issue...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Xiangrong, Jing, Xuan, Yi, Qin, Xiang, Zhongping, Tian, Jie, Tan, Bin, Zhu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412447/
https://www.ncbi.nlm.nih.gov/pubmed/30816520
http://dx.doi.org/10.3892/or.2019.7007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412447/
https://www.ncbi.nlm.nih.gov/pubmed/30816520
http://dx.doi.org/10.3892/or.2019.7007

Ejemplares similares